Ovid Therapeutics
Utility Patents

Last updated:

List of all Ovid Therapeutics patents 21 in total

Status Patent
Grant
Utility: Gaboxadol for therapeutic treatment of 1p36 deletion syndrome External link
Filling date: 6 Sep 2025 Issue date: 21 Jun 2022
Grant
Utility: Use of gaboxadol in the treatment of diabetes and related conditions External link
Filling date: 6 Sep 2025 Issue date: 5 Apr 2022
Grant
Utility: Methods for treating aggression associated with Alzheimer's disease External link
Filling date: 6 Sep 2025 Issue date: 22 Mar 2022
Grant
Utility: Use of MIR-92A or MIR-145 in the treatment of Angelman syndrome External link
Filling date: 6 Sep 2025 Issue date: 28 Sep 2021
Grant
Utility: Methods of treating developmental disorders with gaboxadol External link
Filling date: 6 Sep 2025 Issue date: 24 Aug 2021
Grant
Utility: Use of gaboxadol for the treatment of Tourette syndrome, tics and stuttering External link
Filling date: 6 Sep 2025 Issue date: 17 Aug 2021
Grant
Utility: Methods of treating developmental disorders and/or seizure disorders with etifoxine External link
Filling date: 6 Sep 2025 Issue date: 23 Feb 2021
Grant
Utility: Use of MIR101 or MIR128 in the treatment of seizure disorders External link
Filling date: 6 Sep 2025 Issue date: 22 Dec 2020
Grant
Utility: Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-l-carboxylic acid and related compounds, (1s,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disorders External link
Filling date: 6 Sep 2025 Issue date: 27 Oct 2020
Grant
Utility: Use of Gaboxadol in the treatment of diabetes and related conditions External link
Filling date: 6 Sep 2025 Issue date: 27 Oct 2020
Grant
Utility: Methods and compositions for treatment of epileptic disorders External link
Filling date: 6 Sep 2025 Issue date: 13 Oct 2020
Grant
Utility: Use of gaboxadol for the treatment of Tourette syndrome, tics and stuttering External link
Filling date: 6 Sep 2025 Issue date: 8 Sep 2020
Grant
Utility: Methods of treating developmental encephalopathies External link
Filling date: 6 Sep 2025 Issue date: 8 Sep 2020
Grant
Utility: Methods of treating developmental syndromes with PDE10A inhibitors External link
Filling date: 6 Sep 2025 Issue date: 11 Aug 2020
Grant
Utility: Use of MIR-92A or MIR-145 in the treatment of Angelman syndrome External link
Filling date: 6 Sep 2025 Issue date: 7 Jul 2020
Grant
Utility: Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of tinnitus, acute sensorineural hearing loss, meniere'S disease, tourette'S syndrome, attention deficit hyperactivity disorder and addiction External link
Filling date: 6 Sep 2025 Issue date: 19 May 2020
Grant
Utility: Methods and compositions for treatment of epileptic disorders External link
Filling date: 6 Sep 2025 Issue date: 31 Mar 2020
Grant
Utility: Methods of treating behavioral syndromes using pipradrol External link
Filling date: 6 Sep 2025 Issue date: 3 Dec 2019
Grant
Utility: Methods of treating developmental disorders with biguanides External link
Filling date: 6 Sep 2025 Issue date: 1 Oct 2019
Grant
Utility: Methods of treating developmental disorders and/or seizure disorders with etifoxine External link
Filling date: 6 Sep 2025 Issue date: 24 Sep 2019
Grant
Utility: Methods and compositions for treatment of epileptic disorders External link
Filling date: 6 Sep 2025 Issue date: 30 Jul 2019

Showing 1 to 21 of 21 patents.